Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: PDT

SmartNews launches COVID-19 vaccine tracker in United States and Japan


SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- SmartNews Inc, the leading global news app, launched today its coronavirus vaccine tracking service for both the United States and Japan. The service is an expansion of SmartNews's Coronavirus Real-Time Updates dashboard, providing users a full spectrum of information about the pandemic.

In the United States, the new vaccine tracking service provides simple, easy-to-understand daily updates on vaccinations at the state and national level. Globally, this new addition can be accessed now by more than 20 million monthly active users1 in the United States and Japan.

"SmartNews is committed to providing users with high-quality information that serves the social good," said Ken Suzuki, CEO of SmartNews Inc. "Vaccination against the pandemic has enormous social impact, and we believe it is our responsibility to provide the latest data to all of our users."

This new data is integrated into SmartNews's Coronavirus Real-Time Updates dashboard, which provides the latest data in real-time for users about the number of cases, tests and deaths in the country from the COVID-19 pandemic. It can be accessed through the Coronavirus tab on the SmartNews app.

In the future, SmartNews will continue to  expand the functions of the Coronavirus Real-Time Updates dashboard to provide needed information about the pandemic and the effort to vaccinate against it.

About SmartNews

SmartNews is a leading global news-discovery company, dedicated to delivering quality information to the people who need it. SmartNews provides news that matters to millions of users thanks to its unique machine learning technology and relationships with over 3,000 global publisher partners. Founded in 2012, SmartNews has been downloaded more than 50 million times2 globally. With a $1.2 billion valuation, SmartNews is the first news app unicorn since 2015 and has raised $182 million in total venture funding.

For more information or to download the app, visit: www.smartnews.com

1 Monthly active users as of August 2019.
2 Monthly active users as of October 2019.

SOURCE SmartNews, Inc.


These press releases may also interest you

at 09:35
Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
United States Telehealth Weight Loss Market Report 2024-2028: Impacts of COVID and GLP-1 Meds Featuring Weight Watchers, Noom, Ro.co, , AmWell, Amazon, Teladoc, Form Health, Form Health Among Others - ResearchAndMarkets.com
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against QuidelOrtho Corporation
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

More news about Covid-19 virus...


News published on and distributed by: